KR830001649A - 생체조직 및 혈액과 화합(和合)할 수 있는 물질 - Google Patents

생체조직 및 혈액과 화합(和合)할 수 있는 물질 Download PDF

Info

Publication number
KR830001649A
KR830001649A KR1019800000200A KR800000200A KR830001649A KR 830001649 A KR830001649 A KR 830001649A KR 1019800000200 A KR1019800000200 A KR 1019800000200A KR 800000200 A KR800000200 A KR 800000200A KR 830001649 A KR830001649 A KR 830001649A
Authority
KR
South Korea
Prior art keywords
group
substrate
blood
biological
primary
Prior art date
Application number
KR1019800000200A
Other languages
English (en)
Inventor
아브레이 우드로프 어네스트
Original Assignee
아브레이 우드로프 어네스트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아브레이 우드로프 어네스트 filed Critical 아브레이 우드로프 어네스트
Publication of KR830001649A publication Critical patent/KR830001649A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
    • A61F2310/00383—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A61L2300/214—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S602/00—Surgery: splint, brace, or bandage
    • Y10S602/90—Method of making bandage structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

내용 없음

Description

생채조직 및 혈액과 화합(和合)할 수 있는 물질
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 인간이나 동물에 사용할 수 있는 생체조직 및 현액과 화합할 수 있는 물질에 있어서, 기질의 표면중 적어도 일부에 1차나 2차 아미노기(이 아미노기에는 알데히드기와 아릴-할로겐기등으로 이루어진 기중에서 선택한 바응성기가 부착되어 있다)로 이루어진 기중에서 선택한 작용기를 함유시킨 후, 이 기질표면부에 있는 1차나 2차 아미노기에 부착된 알데히드기나 아릴-할로겐기와 생물학적 제제의 1차나 2차 아민기 또는 히드록실기와의 반응에 의해 생물학적 제제를 기질에 결착시켜 기질표면부가 생체조직이나 결액과 화합(和合)될 수 있도록 생물학적 제제가 작용케한 생체조직 및 혈액과 화합할 수 있는 물질.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019800000200A 1979-01-22 1980-01-21 생체조직 및 혈액과 화합(和合)할 수 있는 물질 KR830001649A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US531979A 1979-01-22 1979-01-22
US5319 1993-01-15

Publications (1)

Publication Number Publication Date
KR830001649A true KR830001649A (ko) 1983-05-18

Family

ID=21715278

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019800000200A KR830001649A (ko) 1979-01-22 1980-01-21 생체조직 및 혈액과 화합(和合)할 수 있는 물질

Country Status (14)

Country Link
US (1) US4828561A (ko)
JP (1) JPS55125870A (ko)
KR (1) KR830001649A (ko)
BE (1) BE881275A (ko)
CA (1) CA1169358A (ko)
DE (1) DE3002038A1 (ko)
DK (1) DK26380A (ko)
GB (1) GB2041377B (ko)
HK (1) HK56488A (ko)
IE (1) IE49066B1 (ko)
IT (1) IT1129710B (ko)
LU (1) LU82102A1 (ko)
NL (1) NL8000330A (ko)
SE (1) SE450869B (ko)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8200751L (sv) * 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
SE456347B (sv) * 1982-02-09 1988-09-26 Ird Biomaterial Ab Ytmodifierat fast substrat samt forfarande for framstellning derav
WO1983003977A1 (en) * 1982-05-14 1983-11-24 Astra Meditec Ab Articles exhibiting a biocompatible surface layer and process for providing articles with such a surface layer
JPS5938150U (ja) * 1982-09-03 1984-03-10 株式会社クボタ 不整地走行用運搬車
SE446688C (sv) * 1982-09-14 1989-10-16 Magnus Hoeoek Medel foer avlaegsnande av mikroorganismer fraan vaevnader, vilket bestaar av ett protein som kan bindas till mikroorganismerna
GB8401534D0 (en) * 1984-01-20 1984-02-22 Royal Free Hosp School Med Biocompatible surfaces
DE3639561A1 (de) * 1986-11-20 1988-06-01 Baumann Hanno Verfahren zur herstellung von nicht-thrombogenen substraten
JPS6425870A (en) * 1987-04-30 1989-01-27 Ajinomoto Kk Support for anastomosis or bonding of living body
US4789601A (en) * 1987-05-04 1988-12-06 Banes Albert J Biocompatible polyorganosiloxane composition for cell culture apparatus
JP2561309B2 (ja) * 1988-03-28 1996-12-04 テルモ株式会社 医療用材料およびその製造方法
US5262451A (en) * 1988-06-08 1993-11-16 Cardiopulmonics, Inc. Multifunctional thrombo-resistant coatings and methods of manufacture
US5338770A (en) * 1988-06-08 1994-08-16 Cardiopulmonics, Inc. Gas permeable thrombo-resistant coatings and methods of manufacture
US5342693A (en) * 1988-06-08 1994-08-30 Cardiopulmonics, Inc. Multifunctional thrombo-resistant coating and methods of manufacture
US5182317A (en) * 1988-06-08 1993-01-26 Cardiopulmonics, Inc. Multifunctional thrombo-resistant coatings and methods of manufacture
JPH0221875A (ja) * 1988-07-11 1990-01-24 Terumo Corp 医療用材料ならびに医療用器具
US5281662A (en) * 1988-08-03 1994-01-25 New England Deaconess Hospital Corporation Anthraquinone dye treated materials
US5019393A (en) * 1988-08-03 1991-05-28 New England Deaconess Hospital Corporation Biocompatible substance with thromboresistance
US5126140A (en) * 1988-08-03 1992-06-30 New England Deaconess Hospital Corporation Thrombomodulin-coated bicompatible substance
FR2649888B1 (fr) * 1989-07-18 1994-08-26 Exsymol Sa Produits pour applications cutanees, a effets cosmetiques ou/et therapeutiques
GB9022938D0 (en) * 1990-10-22 1990-12-05 Biocompatibles Ltd Non-thrombogenic surfaces
ES2103313T3 (es) * 1990-11-05 1997-09-16 Biocompatibles Ltd Esteres de acido fosforico y su utilizacion en la preparacion de superficies biocompatibles.
CA2102234C (en) * 1992-02-04 2008-11-18 Andrzej Breborowicz Peritoneal dialysis composition and method usable during and after peritonitis
ATE169223T1 (de) * 1992-02-04 1998-08-15 Baxter Int Peritonealdialyselösungen die mindestens ein dipeptid enthalten
US5391203A (en) * 1992-04-13 1995-02-21 Scott P. Bartlett Method of draining and filling soft tissue implant
US5407445A (en) * 1992-05-20 1995-04-18 Cytrx Corporation Gel composition for implant prosthesis and method of use
DE4217917A1 (de) * 1992-05-30 1993-12-02 Job Prof Dr Med Harenberg Immobilisation von chemisch kovalent gebundenem Heparin an Polymere mit Arylresten im Polymer
US5342387A (en) * 1992-06-18 1994-08-30 American Biomed, Inc. Artificial support for a blood vessel
DK0784986T3 (da) * 1995-06-07 2002-03-25 Yoshito Ikada Kunstigt hår til implantation og fremgangsmåde tilfremstilling heraf
MX9602398A (es) * 1995-06-23 1997-02-28 Kimberly Clark Co Material polimerico modificado teniendo humectabilidad mejorada.
US5891196A (en) * 1997-04-16 1999-04-06 Baxter International Inc. Method for actively binding heparin to crosslinked biological tissues
US6776792B1 (en) * 1997-04-24 2004-08-17 Advanced Cardiovascular Systems Inc. Coated endovascular stent
EP1001743B1 (fr) * 1997-06-04 2006-02-01 Debio Recherche Pharmaceutique S.A. Implants pour la liberation controlee de principes pharmaceutiquement actifs et procede pour leur fabrication
US6146771A (en) 1997-07-01 2000-11-14 Terumo Cardiovascular Systems Corporation Process for modifying surfaces using the reaction product of a water-insoluble polymer and a polyalkylene imine
US6197289B1 (en) 1997-07-01 2001-03-06 Terumo Cardiovascular Systems Corporation Removal of biologically active agents
WO2001012675A1 (fr) * 1999-08-10 2001-02-22 Seikagaku Corporation Derives de glycosaminoglycane et leur utilisation
EP1365819B1 (en) 2000-08-23 2005-12-07 Thoratec Corporation Coated vascular grafts and methods of use
US6783793B1 (en) 2000-10-26 2004-08-31 Advanced Cardiovascular Systems, Inc. Selective coating of medical devices
US6565659B1 (en) 2001-06-28 2003-05-20 Advanced Cardiovascular Systems, Inc. Stent mounting assembly and a method of using the same to coat a stent
US10098981B2 (en) 2002-08-06 2018-10-16 Baxter International Inc. Biocompatible phase invertable proteinaceous compositions and methods for making and using the same
US9101536B2 (en) * 2002-08-06 2015-08-11 Matrix Medical Llc Biocompatible phase invertable proteinaceous compositions and methods for making and using the same
DE20306637U1 (de) * 2003-04-28 2003-06-26 Gfe Medizintechnik Gmbh Weichteilimplantate wie Brustimplantat, Wadenmuskelprothese o.dgl.
US7198675B2 (en) 2003-09-30 2007-04-03 Advanced Cardiovascular Systems Stent mandrel fixture and method for selectively coating surfaces of a stent
US7563324B1 (en) 2003-12-29 2009-07-21 Advanced Cardiovascular Systems Inc. System and method for coating an implantable medical device
US7553377B1 (en) 2004-04-27 2009-06-30 Advanced Cardiovascular Systems, Inc. Apparatus and method for electrostatic coating of an abluminal stent surface
US20050288684A1 (en) * 2004-06-16 2005-12-29 Aronson Nathan A Method of reducing collateral flow in a portion of a lung
US7553810B2 (en) 2004-06-16 2009-06-30 Pneumrx, Inc. Lung volume reduction using glue composition
US7678767B2 (en) * 2004-06-16 2010-03-16 Pneumrx, Inc. Glue compositions for lung volume reduction
US7394943B2 (en) * 2004-06-30 2008-07-01 Applera Corporation Methods, software, and apparatus for focusing an optical system using computer image analysis
US7244270B2 (en) * 2004-09-16 2007-07-17 Evera Medical Systems and devices for soft tissue augmentation
US20060058890A1 (en) * 2004-09-16 2006-03-16 Lesh Michael D Methods for soft tissue augmentation
US20060058891A1 (en) * 2004-09-16 2006-03-16 Lesh Michael D Transformable tissue bulking device
US7641688B2 (en) * 2004-09-16 2010-01-05 Evera Medical, Inc. Tissue augmentation device
US20060058892A1 (en) * 2004-09-16 2006-03-16 Lesh Michael D Valved tissue augmentation implant
WO2006034077A1 (en) * 2004-09-16 2006-03-30 Juva Medical, Inc. Tissue augmentation device
US7632307B2 (en) 2004-12-16 2009-12-15 Advanced Cardiovascular Systems, Inc. Abluminal, multilayer coating constructs for drug-delivery stents
US7867547B2 (en) 2005-12-19 2011-01-11 Advanced Cardiovascular Systems, Inc. Selectively coating luminal surfaces of stents
US8003156B2 (en) 2006-05-04 2011-08-23 Advanced Cardiovascular Systems, Inc. Rotatable support elements for stents
US8603530B2 (en) 2006-06-14 2013-12-10 Abbott Cardiovascular Systems Inc. Nanoshell therapy
US8048448B2 (en) 2006-06-15 2011-11-01 Abbott Cardiovascular Systems Inc. Nanoshells for drug delivery
US8017237B2 (en) 2006-06-23 2011-09-13 Abbott Cardiovascular Systems, Inc. Nanoshells on polymers
US20100297218A1 (en) * 2006-09-20 2010-11-25 Pneumrx, Inc. Tissue adhesive compositions and methods thereof
US9474833B2 (en) * 2006-12-18 2016-10-25 Cook Medical Technologies Llc Stent graft with releasable therapeutic agent and soluble coating
JP5116010B2 (ja) * 2007-03-13 2013-01-09 独立行政法人産業技術総合研究所 薬物徐放能を備えた抗血栓性材料
US8048441B2 (en) 2007-06-25 2011-11-01 Abbott Cardiovascular Systems, Inc. Nanobead releasing medical devices
BRPI0821158A2 (pt) 2007-12-20 2015-06-16 Novartis Ag Método para fazer lentes de contato
US20090198329A1 (en) 2008-02-01 2009-08-06 Kesten Randy J Breast implant with internal flow dampening
US20090198331A1 (en) * 2008-02-01 2009-08-06 Kesten Randy J Implantable prosthesis with open cell flow regulation
US20090234305A1 (en) * 2008-03-15 2009-09-17 Ernest Aubrey Woodroof Temporary skin substitute comprised of biological compounds of plant and animal origins
US20100030170A1 (en) * 2008-08-01 2010-02-04 Keith Alan Keller Absorptive Pad
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
EP2516570B1 (en) * 2009-12-23 2017-01-25 DSM IP Assets B.V. Method to activate silicone rubber surfaces
US20110155141A1 (en) * 2009-12-28 2011-06-30 Sawyer Lawrence H Wearable Article That Stiffens Upon Sudden Force
CN113694272A (zh) 2015-03-10 2021-11-26 希玛奈克斯特股份有限公司 氧减少一次性套件、装置及其使用方法
EP3297641A4 (en) 2015-05-18 2019-02-06 New Health Sciences, Inc. METHODS FOR TOTAL BLOOD STORAGE AND CORRESPONDING COMPOSITIONS
ES2910948T3 (es) 2016-05-27 2022-05-17 Hemanext Inc Almacenamiento anaeróbico de sangre y procedimiento de inactivación de patógenos
WO2023181081A1 (en) * 2022-03-21 2023-09-28 Haskoli Islands Surface activation of silicone

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3457098A (en) * 1966-08-18 1969-07-22 Us Health Education & Welfare Nonthrombogenic plastic surfaces and preparation thereof
US3846353A (en) * 1970-06-08 1974-11-05 Department Of Health Education Nonthrombogenic plastic material and method for making the same
DE2148011C3 (de) * 1970-10-05 1978-11-09 Aminkemi Ab Verfahren zum Herstellen nichtthrombogener Kunststoffoberflächen
US3826678A (en) * 1972-06-06 1974-07-30 Atomic Energy Commission Method for preparation of biocompatible and biofunctional materials and product thereof
US4001583A (en) * 1974-10-04 1977-01-04 Barrett M James Covalently bound biological substances to plastic materials and use in radioassay
SE425372B (sv) * 1977-07-18 1982-09-27 Ird Biomaterial Ab Sett att heparinisera en elektriskt laddad yta pa en medecinsk artikel avsedd att komma i kontakt med blod och medel for utforande av settet

Also Published As

Publication number Publication date
IT1129710B (it) 1986-06-11
DE3002038A1 (de) 1980-07-31
JPS6137952B2 (ko) 1986-08-26
IT8019372A0 (it) 1980-01-22
BE881275A (nl) 1980-05-16
DK26380A (da) 1980-07-23
SE8000449L (sv) 1980-07-23
GB2041377A (en) 1980-09-10
NL8000330A (nl) 1980-07-24
IE49066B1 (en) 1985-07-24
GB2041377B (en) 1983-09-28
JPS55125870A (en) 1980-09-29
LU82102A1 (fr) 1980-04-23
DE3002038C2 (ko) 1990-12-06
IE800110L (en) 1980-07-22
HK56488A (en) 1988-08-05
US4828561A (en) 1989-05-09
SE450869B (sv) 1987-08-10
CA1169358A (en) 1984-06-19

Similar Documents

Publication Publication Date Title
KR830001649A (ko) 생체조직 및 혈액과 화합(和合)할 수 있는 물질
KR890001626A (ko) Fr-900506 물질의 고체 분산 조성물
KR830005862A (ko) 인체 에리트로포에틴의 제조방법
DK163668C (da) Polymerpartikler med kerne-skal-opbygning, der er redispergerbare i en vaeske til dannelse af en latex til brug ved immobilisering af biologisk aktive stoffer
JPS6465456A (en) Improved activity and coupled polystyrene support
KR840005083A (ko) 항고혈압제로서 유용한 아미노산유도체의 제조방법
SE8000470L (sv) Vevnadsbindmedel och forfarande for dess framstellning samt bindmedlets anvendning
KR830002803A (ko) 5'-데옥시-5-플루오로우리딘의 제법
KR830005863A (ko) 인체 융모성선자격 호르몬의 제조방법
ES2068817T3 (es) Procedimiento inmunologico de identificacion para herbicidas.
IT7924838A0 (it) Procedimento per la preparazione di materiali biocompatibili tramite l'immobilizzazione superficiale di apirasi.
FR2656346B1 (fr) Feuille souple, resistant a la dechirure et l'eclatement, peu absorbante aux liquides et a porosite controlee.
KR920018076A (ko) 신규 폴리펩티드
ES2074983T3 (es) Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales.
KR830004414A (ko) 마이코페놀산 유도체의 제조방법
KR840008328A (ko) 에폭시화합물의 경화방법 및 경화촉진 방법
JPS57143370A (en) Water-based adhesive for paper
KR870006024A (ko) 니자티딘의 제조방법
KR830005867A (ko) 인체 프롤랙틴의 제조 방법
JPS52154520A (en) Modified antibody and its preparation
JPS53124682A (en) Preparation of complex of enzyme and bioactive substance and its use
KR900012622A (ko) 피부질환치료 조성물
BR7908296A (pt) Derivados de qunoxalino-di-n-oxido,processo para a sua preparacao composicoes para o o combate de microorganismos prejuciais e seu emprego
KR900015747A (ko) 간장관련 질병 치료제의 제조방법
SU655680A1 (ru) Композици дл склеивани материалов